Coronavirus vaccine compositions and methods
US11744887B2 · kind B2 · utility
2Cited by
14References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 9, 2021 |
| Grant date | Sep 5, 2023 |
| Priority date | — |
| Expiry date | Dec 9, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are nucleic acid molecules encoding viral replication proteins and antigenic coronavirus proteins or fragments thereof. Also provided herein are compositions that include nucleic acid molecules encoding viral replication and antigenic proteins, and lipids. Nucleic acid molecules provided herein are useful for inducing immune responses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.